• Publications
  • Influence
Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles
After adjuvant chemotherapy, the majority of young Chinese breast cancer patients developed CRA; ~50% developed CRM, with 61% at age ≤45, and age at diagnosis is the only factor associated with CRM. Expand
Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy
Among young premenopausal Chinese breast cancer patients who had received adjuvant chemotherapy, the current study has revealed that although there was only a median weight gain, there was a nearly 60% increase in abnormal BMI and a significant proportion of patients were detected to have hypertension and dyslipidaemias. Expand
Quality of life of young Chinese breast cancer patients after adjuvant chemotherapy
At a median follow-up of 5 years post-diagnosis, patients who were younger had fewer disturbances in their SWB, and further studies are warranted for breast-specific QoL to address the specific issues encountered by breast cancer patients. Expand
State of the Art Antiemetic Therapy for Cancer Patients
The cornerstone of effective management of nausea and vomiting secondary to these antineoplastic drugs is the prevention with the use of appropriate guideline-directed combination antiemetic regimen. Expand
Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors
  • W. Yeo, E. Pang, +6 authors F. Mo
  • Medicine
  • Health and quality of life outcomes
  • 10 February 2020
Among premenopausal breast cancer women who had undergone adjuvant chemotherapy, those who had received taxanes or tamoxifen, were overweight/obese and utilized traditional Chinese medicine had more severe menopausal symptoms. Expand
Bone Health in Premenopausal Chinese Patients after Adjuvant Chemotherapy for Early Breast Cancer
About 5 years after breast cancer diagnosis and adjUvant chemotherapy, >50% of premenopausal patients who had received adjuvant chemotherapy were detected to have osteopenia/osteoporosis and 40% had abnormal Z-scores for FN/LS. Expand